• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Teddy Rosenbluth
Author: Teddy Rosenbluth

Written by

Teddy Rosenbluth

in

Appointments and Executive Changes, Cassava Sciences Inc, City College of New York, Clinical Trials, Drugs (Pharmaceuticals), Falsification of Data, Research, Securities and Commodities Violations
←Biden’s Student Loan Repayment Plan Blocked by Federal Appeals Court
Imagery Of A Bloodied Trump And Calls To ‘Fight’ Are Everywhere At The RNC→

More posts

  • Ramy Youssef Defends Teaching Elmo Arabic On ‘Sesame Street’ After Fox News Backlash: “It Just Means Peace”

  • Fernandez fires Chelsea to FA Cup final showdown with Man City

  • Blanche says administration officials were apparent targets at correspondents’ dinner

  • Oz Pearlman recounts WHCA dinner shooting: ‘Really shocking’

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube